Recursion Pharma (RXRX): Price-to-Sales Ratio

Corporate company logo of Recursion Pharma (RXRX)

Patent-protected algorithms and unique biodata create a technological barrier for competitors of Recursion Pharmaceuticals (RXRX). The price-to-sales ratio in the daily price action on the GURU.Markets chart has reached a level where the current value equals 27.20. Partnerships with Nvidia, Roche, and Bayer are driving growth, while the revolutionary digitization of biology via robotics radically accelerates the creation of new drugs and reduces development costs.

RXRX: recursion.com P/S Multiple 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Recursion Pharma (RXRX)

- share price and consensus valuation forecast:
Price Performance Chart Recursion Pharmaceuticals, Inc.|RXRX - Price Target Chart
- stock exchange capitalization data:
Market Valuation Recursion Pharma|RXRX - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share Recursion|RXRX - Book Capitalization|Market Capitalization to Book Value Ratio recursion.com|RXRX - Aggregate Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Recursion Pharmaceuticals|RXRX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Recursion Corp|RXRX - Company Aggregate Debts|Debts to Book Capitalization Recursion Pharma|RXRX - Company Long-Term Debts|Company Current Liabilities Recursion|Immediate Liquidity recursion.com
- earnings and valuation multiples information:
RXRX - Net Income|Projected Future Earnings Recursion Pharmaceuticals|RXRX - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Recursion|RXRX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Recursion Pharma|RXRX - Operating profit EBITDA|Net earnings per share for the last 12 months Recursion|RXRX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth recursion.com|RXRX - Earnings per share growth in current year|Net earnings per share growth forecast for next year Recursion Pharmaceuticals
- issuer revenue and sales details:
RXRX - Company Revenue|Company Future Sales Recursion Pharma|RXRX - Price-to-Revenue Ratio|Forward Price to Sales Recursion Pharma
General company analysis:RXRX recursion.com
Finished products of Recursion Pharmaceuticals

Stable funding for Recursion Pharmaceuticals (RXRX) through long-term contracts with pharma behemoths minimizes the impact of market cyclicality on the business. The current value of 27.20 reflects the market value of one dollar of revenue, allowing investors to assess whether the asset is overbought or has growth potential by analyzing the price-to-sales ratio dynamics on this chart.

Competing companies

NVDA (nvidia.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio CoreWeave CRWV|NBIS (Nebius Group NV) - Price-to-Sales Ratio|SoundHound Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio ZETA (Zeta Global Holdings)|PGY: P/S Multiple|C3.ai Inc (AI) - P/S Multiple|Price-to-Revenue Ratio Rezolve AI|SUPX: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Ginkgo Corp (DNA)|Market Cap to Revenue Cerence AI CRNC|P/S Multiple PDYN (Palladyne AI Corp.)|P/S Multiple Veritone Inc. VERI|Mint Inc - P/S Multiple|MicroAlgo Inc. (MLGO) - Market Cap to Revenue|HPAI: P/S Multiple|Price to Sales LivePerson Inc. (LPSN)|Market Cap to Revenue QUIK|P/S Multiple System1 Group|Market Cap to Revenue DVLT (Datavault AI)|Market Cap to Sales Volume RYET|P/S Multiple WETO (Webus)|Price-to-Revenue Coefficient Micropolis Corp (MCRP)|Cyanogen - P/S Multiple|Connexa Sports Technologies (YYAI) - Market Cap to Revenue|HOLO: P/S Multiple|MultiSensor AI Holdings Inc. (MSAI) - P/S Multiple|Price-to-Revenue Ratio Evaxion Biotech Corp|Price-to-Revenue Ratio AIXI|Price-to-Revenue Ratio CXApp Inc. (CXAI)|Price-to-Revenue Coefficient beninc.ai|Price-to-Revenue Ratio Gaxos.ai GXAI|Market Capitalization-to-Revenue Ratio EVGN|IFBD: Market Cap to Revenue|TAOP (China Information Technology) - Market Cap to Revenue Ratio|verses.ai (VSAI) - Price-to-Revenue Ratio|Exscientia - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue FOXO|Market Cap to Revenue Ratio VHAI (Vocodia)|P/S Multiple ZPTA